Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ITEM phase II study of imatinib in metastatic uveal melanoma
ISRCTN91548930Phase 2Completed
- Sponsor
- Clatterbridge Cancer Centre
- Start
- Apr 2008
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of imatinib in intraocular melanoma, sponsored by Clatterbridge Cancer Centre. Primary endpoint: Progression-free survival at 3 months. Started Apr 2008; status: completed.
02
Drugs
03
Conditions
intraocular melanoma
Beyond the preview
Go deeper on ISRCTN91548930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN91548930.